Who
David J. Wambeke
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, NeuroOne Medical Technologies; Chief Business Officer, DiaMedica Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 5
- Sells
- 0
- Bought
- $2.4M
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 Apr 2023
- Last trade
- 28 Aug 2026
- Last filed
- 8 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 8 Sep 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 28 Aug 2026filed 8 Sep 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 27 Aug 2026filed 8 Sep 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $67K33,333 at $2.01 | filing |
| 27 Aug 2026filed 8 Sep 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $67K33,333 at $2.01 | filing |
| 1 Mar 2026filed 3 Mar 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $670K1,000,000 at $0.6704 | filing |
| 1 Mar 2026filed 3 Mar 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | NMTC NeuroOne Medical Technologiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | NMTC NeuroOne Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $670K1,000,000 at $0.67 | filing |
| 1 Jun 2025filed 3 Jun 2025 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 1 Jun 2024filed 3 Jun 2024 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 16 Nov 2023filed 16 Nov 2023 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $49K20,000 at $2.46 | filing |
| 23 Jun 2023filed 26 Jun 2023 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $150K38,364 at $3.91 | filing |
| 10 Apr 2023filed 11 Apr 2023 | DMAC DiaMedica Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 10 Apr 2023filed 11 Apr 2023 | DMAC DiaMedica TherapeuticsBiotechnology | SEC FORM 4 Bought | $750K468,750 at $1.60 | filing |
News
Comparing NeuroOne Medical Technologies (NASDAQ:NMTC) and Innovative Eyewear (NASDAQ:LUCY)NMTC · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name David J. Wambeke; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.